ÂÜÀòÂÒÂ×

Gerardo Pangilinan, MS, DABT, is an accomplished toxicologist with extensive experience in nonclinical safety studies and regulatory submissions. Currently serving as Principal Scientist at FibroGen, Inc. since May 2020, Gerardo has previously held roles such as Toxicology Consultant and Research Associates Supervisor at various companies, contributing expertise in data analysis, study design, and compliance with regulatory guidelines. Gerardo's background includes significant positions at Pain Therapeutics, Amgen, and Roche, where Gerardo managed toxicology programs, supervised research teams, and played a key role in submitting various drug applications. Gerardo holds a Master's degree in Animal Science from the Agricultural University of Norway and a Bachelor's degree in Animal Science from the University of the Philippines.